| Savio Reddymasu, MD | |
|
500 W Thomas Rd Ste 100, Phoenix, AZ 85013-4255 | |
| (602) 406-1510 | |
| (602) 406-7277 |
| Full Name | Savio Reddymasu |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 23 Years |
| Location | 500 W Thomas Rd Ste 100, Phoenix, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598981979 | NPI | - | NPPES |
| 098684244 | Other | NE | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 56312 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Gilbert Medical Center | Gilbert, AZ | Hospital |
| St. Joseph's Hospital And Medical Center | Phoenix, AZ | Hospital |
| Abrazo Central Campus | Phoenix, AZ | Hospital |
| Abrazo Scottsdale Campus | Phoenix, AZ | Hospital |
| Yavapai Regional Medical Center | Prescott, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Digestive Institute Of Arizona Pllc | 1052776358 | 4 |
| Sjhmc Physician Services | 4486646197 | 533 |
| Vhs Outpatient Clinics Inc | 4486566726 | 157 |
News Archive
Kaiser Health News reports that vulnerable Democrats are looking for alternatives to the health law's mandate that nearly all Americans carry health insurance. "Under political pressure as a result of the new health law, Sen. Ben Nelson, D-Neb., has asked the Government Accountability Office to study alternatives to the controversial mandate requiring most Americans to obtain coverage." Because Nelson is from a typically "red" state, Republicans have targeted him as one Democrat willing to play ball on scaling back the law (Vaida, 11/17).
Consumers coping with the high cost of health insurance are the target market for new plans claiming to be lower-cost alternatives to the Affordable Care Act that fulfill the law's requirement for health coverage.
Mylan Laboratories Inc. has announced that the U.S. Court of Appeals for the Federal Circuit upheld a district court decision that Mylan's Oxybutynin products do not infringe a patent for DITROPAN XL and that the patent was invalid.
People who have been diagnosed with panic attacks or panic disorder have a greater risk of subsequently developing heart disease or suffering a heart attack than the normal population, with higher rates occurring in younger people, according to research published in Europe's leading cardiology journal, the European Heart Journal.
Researchers working in a research project within the Academy of Finland's Research Programme on Substance Use and Addictions have been developing a targeted drug that could aid in smoking reduction therapy. The new drug slows down the metabolism of nicotine, which would help smokers to cut down their smoking.
› Verified 8 days ago
| Entity Name | Vhs Outpatient Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912979964 PECOS PAC ID: 4486566726 Enrollment ID: O20031104000523 |
News Archive
Kaiser Health News reports that vulnerable Democrats are looking for alternatives to the health law's mandate that nearly all Americans carry health insurance. "Under political pressure as a result of the new health law, Sen. Ben Nelson, D-Neb., has asked the Government Accountability Office to study alternatives to the controversial mandate requiring most Americans to obtain coverage." Because Nelson is from a typically "red" state, Republicans have targeted him as one Democrat willing to play ball on scaling back the law (Vaida, 11/17).
Consumers coping with the high cost of health insurance are the target market for new plans claiming to be lower-cost alternatives to the Affordable Care Act that fulfill the law's requirement for health coverage.
Mylan Laboratories Inc. has announced that the U.S. Court of Appeals for the Federal Circuit upheld a district court decision that Mylan's Oxybutynin products do not infringe a patent for DITROPAN XL and that the patent was invalid.
People who have been diagnosed with panic attacks or panic disorder have a greater risk of subsequently developing heart disease or suffering a heart attack than the normal population, with higher rates occurring in younger people, according to research published in Europe's leading cardiology journal, the European Heart Journal.
Researchers working in a research project within the Academy of Finland's Research Programme on Substance Use and Addictions have been developing a targeted drug that could aid in smoking reduction therapy. The new drug slows down the metabolism of nicotine, which would help smokers to cut down their smoking.
› Verified 8 days ago
| Entity Name | Sjhmc Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326098005 PECOS PAC ID: 4486646197 Enrollment ID: O20040401001189 |
News Archive
Kaiser Health News reports that vulnerable Democrats are looking for alternatives to the health law's mandate that nearly all Americans carry health insurance. "Under political pressure as a result of the new health law, Sen. Ben Nelson, D-Neb., has asked the Government Accountability Office to study alternatives to the controversial mandate requiring most Americans to obtain coverage." Because Nelson is from a typically "red" state, Republicans have targeted him as one Democrat willing to play ball on scaling back the law (Vaida, 11/17).
Consumers coping with the high cost of health insurance are the target market for new plans claiming to be lower-cost alternatives to the Affordable Care Act that fulfill the law's requirement for health coverage.
Mylan Laboratories Inc. has announced that the U.S. Court of Appeals for the Federal Circuit upheld a district court decision that Mylan's Oxybutynin products do not infringe a patent for DITROPAN XL and that the patent was invalid.
People who have been diagnosed with panic attacks or panic disorder have a greater risk of subsequently developing heart disease or suffering a heart attack than the normal population, with higher rates occurring in younger people, according to research published in Europe's leading cardiology journal, the European Heart Journal.
Researchers working in a research project within the Academy of Finland's Research Programme on Substance Use and Addictions have been developing a targeted drug that could aid in smoking reduction therapy. The new drug slows down the metabolism of nicotine, which would help smokers to cut down their smoking.
› Verified 8 days ago
| Entity Name | Yavapai Regional Medical Center Physician Care, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255582003 PECOS PAC ID: 5294898987 Enrollment ID: O20090106000798 |
News Archive
Kaiser Health News reports that vulnerable Democrats are looking for alternatives to the health law's mandate that nearly all Americans carry health insurance. "Under political pressure as a result of the new health law, Sen. Ben Nelson, D-Neb., has asked the Government Accountability Office to study alternatives to the controversial mandate requiring most Americans to obtain coverage." Because Nelson is from a typically "red" state, Republicans have targeted him as one Democrat willing to play ball on scaling back the law (Vaida, 11/17).
Consumers coping with the high cost of health insurance are the target market for new plans claiming to be lower-cost alternatives to the Affordable Care Act that fulfill the law's requirement for health coverage.
Mylan Laboratories Inc. has announced that the U.S. Court of Appeals for the Federal Circuit upheld a district court decision that Mylan's Oxybutynin products do not infringe a patent for DITROPAN XL and that the patent was invalid.
People who have been diagnosed with panic attacks or panic disorder have a greater risk of subsequently developing heart disease or suffering a heart attack than the normal population, with higher rates occurring in younger people, according to research published in Europe's leading cardiology journal, the European Heart Journal.
Researchers working in a research project within the Academy of Finland's Research Programme on Substance Use and Addictions have been developing a targeted drug that could aid in smoking reduction therapy. The new drug slows down the metabolism of nicotine, which would help smokers to cut down their smoking.
› Verified 8 days ago
| Entity Name | District Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336472448 PECOS PAC ID: 7315086691 Enrollment ID: O20091125000583 |
News Archive
Kaiser Health News reports that vulnerable Democrats are looking for alternatives to the health law's mandate that nearly all Americans carry health insurance. "Under political pressure as a result of the new health law, Sen. Ben Nelson, D-Neb., has asked the Government Accountability Office to study alternatives to the controversial mandate requiring most Americans to obtain coverage." Because Nelson is from a typically "red" state, Republicans have targeted him as one Democrat willing to play ball on scaling back the law (Vaida, 11/17).
Consumers coping with the high cost of health insurance are the target market for new plans claiming to be lower-cost alternatives to the Affordable Care Act that fulfill the law's requirement for health coverage.
Mylan Laboratories Inc. has announced that the U.S. Court of Appeals for the Federal Circuit upheld a district court decision that Mylan's Oxybutynin products do not infringe a patent for DITROPAN XL and that the patent was invalid.
People who have been diagnosed with panic attacks or panic disorder have a greater risk of subsequently developing heart disease or suffering a heart attack than the normal population, with higher rates occurring in younger people, according to research published in Europe's leading cardiology journal, the European Heart Journal.
Researchers working in a research project within the Academy of Finland's Research Programme on Substance Use and Addictions have been developing a targeted drug that could aid in smoking reduction therapy. The new drug slows down the metabolism of nicotine, which would help smokers to cut down their smoking.
› Verified 8 days ago
| Entity Name | Digestive Institute Of Arizona Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184320384 PECOS PAC ID: 1052776358 Enrollment ID: O20230419003071 |
News Archive
Kaiser Health News reports that vulnerable Democrats are looking for alternatives to the health law's mandate that nearly all Americans carry health insurance. "Under political pressure as a result of the new health law, Sen. Ben Nelson, D-Neb., has asked the Government Accountability Office to study alternatives to the controversial mandate requiring most Americans to obtain coverage." Because Nelson is from a typically "red" state, Republicans have targeted him as one Democrat willing to play ball on scaling back the law (Vaida, 11/17).
Consumers coping with the high cost of health insurance are the target market for new plans claiming to be lower-cost alternatives to the Affordable Care Act that fulfill the law's requirement for health coverage.
Mylan Laboratories Inc. has announced that the U.S. Court of Appeals for the Federal Circuit upheld a district court decision that Mylan's Oxybutynin products do not infringe a patent for DITROPAN XL and that the patent was invalid.
People who have been diagnosed with panic attacks or panic disorder have a greater risk of subsequently developing heart disease or suffering a heart attack than the normal population, with higher rates occurring in younger people, according to research published in Europe's leading cardiology journal, the European Heart Journal.
Researchers working in a research project within the Academy of Finland's Research Programme on Substance Use and Addictions have been developing a targeted drug that could aid in smoking reduction therapy. The new drug slows down the metabolism of nicotine, which would help smokers to cut down their smoking.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Savio Reddymasu, MD 3030 N Central Ave Ste 1001, Phoenix, AZ 85012-2716 Ph: (602) 406-4786 | Savio Reddymasu, MD 500 W Thomas Rd Ste 100, Phoenix, AZ 85013-4255 Ph: (602) 406-1510 |
News Archive
Kaiser Health News reports that vulnerable Democrats are looking for alternatives to the health law's mandate that nearly all Americans carry health insurance. "Under political pressure as a result of the new health law, Sen. Ben Nelson, D-Neb., has asked the Government Accountability Office to study alternatives to the controversial mandate requiring most Americans to obtain coverage." Because Nelson is from a typically "red" state, Republicans have targeted him as one Democrat willing to play ball on scaling back the law (Vaida, 11/17).
Consumers coping with the high cost of health insurance are the target market for new plans claiming to be lower-cost alternatives to the Affordable Care Act that fulfill the law's requirement for health coverage.
Mylan Laboratories Inc. has announced that the U.S. Court of Appeals for the Federal Circuit upheld a district court decision that Mylan's Oxybutynin products do not infringe a patent for DITROPAN XL and that the patent was invalid.
People who have been diagnosed with panic attacks or panic disorder have a greater risk of subsequently developing heart disease or suffering a heart attack than the normal population, with higher rates occurring in younger people, according to research published in Europe's leading cardiology journal, the European Heart Journal.
Researchers working in a research project within the Academy of Finland's Research Programme on Substance Use and Addictions have been developing a targeted drug that could aid in smoking reduction therapy. The new drug slows down the metabolism of nicotine, which would help smokers to cut down their smoking.
› Verified 8 days ago
Moustafa I Hazin, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 500 W Thomas Rd, Suite 900, Phoenix, AZ 85013 Phone: 602-406-5590 Fax: 602-406-7165 | |
Dr. Ali Shaheen Al-yaqoobi, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 2601 E Roosevelt St, Phoenix, AZ 85008 Phone: 602-344-5411 | |
Dana Archbold, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1111 E Mcdowell Rd, Phoenix, AZ 85006 Phone: 602-839-2296 Fax: 602-839-2084 | |
Catalina Nicole Flores, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 350 W Thomas Rd Dept Of, Phoenix, AZ 85013 Phone: 602-406-3000 | |
Kristina Yancey, Gastroenterology Medicare: Medicare Enrolled Practice Location: 5777 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-342-2000 | |
Dr. Francisco Cordova, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 29 W Edgemont Ave, Phoenix, AZ 85003 Phone: 602-263-8971 Fax: 602-263-8971 | |
Dr. Dimpy Kapoor, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9305 W Thomas Rd, Ste 455, Phoenix, AZ 85037 Phone: 623-399-9010 Fax: 623-399-9013 |